Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $43 | In Stock | |
25 mg | $78 | In Stock | |
50 mg | $133 | In Stock | |
100 mg | $198 | In Stock | |
200 mg | $297 | In Stock | |
500 mg | $513 | In Stock | |
1 g | $729 | In Stock | |
1 mL x 10 mM (in DMSO) | $48 | In Stock |
Description | Levocetirizine Dihydrochloride (Xyzal Dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Acting as an antihistaminic agent, it specifically targets the histamine H1-receptor. Levocetirizine Dihydrochloride is the R-enantiomer of Cetirizine, which gives it a higher affinity for the H1-receptor than the S-enantiomer. Due to this enhanced affinity, Levocetirizine Dihydrochloride is effective in treating allergic rhinitis and chronic idiopathic urticaria. |
In vivo | Levocetirizine (0.4 mg/kg; oral administration; male Sprague-Dawley rats) yields a Cmax of 0.34 μg/mL, an AUC0-t of 3.26 μg h/mL, an AUC0-∞ of 3.67 μg h/mL, and a t1/2 of 2.34 hours in Sprague-Dawley rats[1]. |
Alias | Xyzal Dihydrochloride, (-)-Cetirizine Dihydrochloride |
Molecular Weight | 461.81 |
Formula | C21H27Cl3N2O3 |
Cas No. | 130018-87-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 90 mg/mL (194.9 mM), Sonication is recommended. DMSO: 50 mg/mL (108.27 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.